PIH8 Cost-Effectiveness Analysis Of Dasatinib Versus Imatinib In Treating Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients In China
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.526
https://www.valueinhealthjournal.com/article/S1098-3015(21)00743-9/fulltext
Title :
PIH8 Cost-Effectiveness Analysis Of Dasatinib Versus Imatinib In Treating Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients In China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00743-9&doi=10.1016/j.jval.2021.04.526
First page :
Section Title :
Open access? :
No
Section Order :
10011